Clinical Trial Update: Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two doses of temsirolimus (Torisel) in patients with mantle cell lymphoma/non-Hodgkin's lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Pfizer | Conditions: Non-Hodgkin's Lymphoma | Phase 4 | Status: COMPLETED | Results posted: 2017-05-19